Literature DB >> 28647697

Analysis of K-Ras Interactions by Biotin Ligase Tagging.

Christopher Ritchie1, Andrew Mack1, Logan Harper1, Ayna Alfadhli1, Philip J S Stork2, Xiaolin Nan3, Eric Barklis4.   

Abstract

BACKGROUND: Mutations of the human K-Ras 4B (K-Ras) G protein are associated with a significant proportion of all human cancers. Despite this fact, a comprehensive analysis of K-Ras interactions is lacking. Our investigations focus on characterization of the K-Ras interaction network.
MATERIALS AND METHODS: We employed a biotin ligase-tagging approach, in which tagged K-Ras proteins biotinylate neighbor proteins in a proximity-dependent fashion, and proteins are identified via mass spectrometry (MS) sequencing.
RESULTS: In transfected cells, a total of 748 biotinylated proteins were identified from cells expressing biotin ligase-tagged K-Ras variants. Significant differences were observed between membrane-associated variants and a farnesylation-defective mutant. In pancreatic cancer cells, 56 K-Ras interaction partners were identified. Most of these were cytoskeletal or plasma membrane proteins, and many have been identified previously as potential cancer biomarkers.
CONCLUSION: Biotin ligase tagging offers a rapid and convenient approach to the characterization of K-Ras interaction networks. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Proximity mapping; pancreatic cancer; subcellular localization

Mesh:

Substances:

Year:  2017        PMID: 28647697      PMCID: PMC5572301          DOI: 10.21873/cgp.20034

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  96 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 2.  Ras GTPases: integrins' friends or foes?

Authors:  Kayoko Kinbara; Lawrence E Goldfinger; Malene Hansen; Fan-Li Chou; Mark H Ginsberg
Journal:  Nat Rev Mol Cell Biol       Date:  2003-10       Impact factor: 94.444

3.  Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.

Authors:  K Giehl; B Skripczynski; A Mansard; A Menke; P Gierschik
Journal:  Oncogene       Date:  2000-06-08       Impact factor: 9.867

4.  Biological assays for Ras transformation.

Authors:  G J Clark; A D Cox; S M Graham; C J Der
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  RanGAP1 induces GTPase activity of nuclear Ras-related Ran.

Authors:  F R Bischoff; C Klebe; J Kretschmer; A Wittinghofer; H Ponstingl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Second-site compensatory mutations of HIV-1 capsid mutations.

Authors:  Colleen M Noviello; Claudia S López; Ben Kukull; Henry McNett; Amelia Still; Jacob Eccles; Rachel Sloan; Eric Barklis
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.

Authors:  Helen B Pearson; Pedro A Perez-Mancera; Lukas E Dow; Andrew Ryan; Pierre Tennstedt; Debora Bogani; Imogen Elsum; Andy Greenfield; David A Tuveson; Ronald Simon; Patrick O Humbert
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 8.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

9.  A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.

Authors:  Kyle J Roux; Dae In Kim; Manfred Raida; Brian Burke
Journal:  J Cell Biol       Date:  2012-03-12       Impact factor: 10.539

10.  Analysis of k-ras nuclear expression in fibroblasts and mesangial cells.

Authors:  Isabel Fuentes-Calvo; Ana M Blázquez-Medela; Eugenio Santos; José M López-Novoa; Carlos Martínez-Salgado
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more
  5 in total

1.  Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.

Authors:  Eric Barklis; August O Staubus; Andrew Mack; Logan Harper; Robin Lid Barklis; Ayna Alfadhli
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

Review 2.  The Ins and Outs of RAS Effector Complexes.

Authors:  Christina Kiel; David Matallanas; Walter Kolch
Journal:  Biomolecules       Date:  2021-02-07

3.  Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.

Authors:  Derek K Cheng; Tobiloba E Oni; Jennifer S Thalappillil; Youngkyu Park; Hsiu-Chi Ting; Brinda Alagesan; Nadia V Prasad; Kenneth Addison; Keith D Rivera; Darryl J Pappin; Linda Van Aelst; David A Tuveson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

4.  Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity.

Authors:  Hema Adhikari; Walaa E Kattan; Shivesh Kumar; Pei Zhou; John F Hancock; Christopher M Counter
Journal:  Nat Commun       Date:  2021-09-09       Impact factor: 17.694

5.  Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis.

Authors:  Snehangshu Kundu; Muhammad Akhtar Ali; Niklas Handin; Louis P Conway; Veronica Rendo; Per Artursson; Liqun He; Daniel Globisch; Tobias Sjöblom
Journal:  J Exp Clin Cancer Res       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.